Nova Patents
NO971684L

Novel benzoxazoles

Abstract

New compounds that are effective PDE IV inhibitors are described. The compounds exhibit improved PDE IV inhibition similar to theophylline or rolipram, with improved selectivity with respect to e.g. PDE III inhibition.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

209 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
32173094United States of AmericaA
32173094United States of AmericaA
46709195United States of AmericaA
46709195United States of AmericaA
9514399United States of AmericaW
9514399United States of AmericaW
9514399–––
32173094–––
46709195–––
US19940321730–––
US19950467091–––
WO1995US14399–––

Members209

Family members, oldest first
DocumentOfficeKind
CA2193725A1CanadaA1
WO9600218A1World Intellectual Property Organization (WIPO)A1
AU3070695AAustraliaA
IL115563D0IsraelD0
ZA955274BSouth AfricaB
IL116381D0IsraelD0
IL116382D0IsraelD0
CA2202273A1CanadaA1
WO9611917A1World Intellectual Property Organization (WIPO)A1
AU4231796AAustraliaA
ZA958563BSouth AfricaB
ZA9510594BSouth AfricaB
ZA9510595BSouth AfricaB
CA2206287A1CanadaA1
CA2206804A1CanadaA1
WO9618399A1World Intellectual Property Organization (WIPO)A1
WO9618400A1World Intellectual Property Organization (WIPO)A1
AU4527896AAustraliaA
AU4527996AAustraliaA
CA2209125A1CanadaA1
WO9621435A1World Intellectual Property Organization (WIPO)A1
AU4756696AAustraliaA
US5591776AUnited States of AmericaA
EP0766676A1European Patent Office (EPO)A1
NO971684D0NorwayD0
FI971489AFinlandA
FI971489A7FinlandA7
FI971489LFinlandL
NO971684LThis recordNorwayL
EP0785927A1European Patent Office (EPO)A1
PL319605A1PolandA1
US5665737AUnited States of AmericaA
TW315369BTaiwan Province of ChinaB
EP0796093A1European Patent Office (EPO)A1
EP0799040A1European Patent Office (EPO)A1
SK45497A3SlovakiaA3
BG101422ABulgariaA
CA2257807A1CanadaA1
WO9746561A1World Intellectual Property Organization (WIPO)A1
EP0785927A4European Patent Office (EPO)A4
MX9700068AMexicoA
AU3410097AAustraliaA
EP0814809A1European Patent Office (EPO)A1
JPH10502354AJapanA
EP0799040A4European Patent Office (EPO)A4
EP0814809A4European Patent Office (EPO)A4
EP0796093A4European Patent Office (EPO)A4
EP0766676A4European Patent Office (EPO)A4
JPH10508032AJapanA
AU695230B2AustraliaB2
JPH10510513AJapanA
IL114315D0IsraelD0
AU699489B2AustraliaB2
US5864037AUnited States of AmericaA
AU9139398AAustraliaA
US5665737B1United States of AmericaB1
US5889014AUnited States of AmericaA
AU1856499AAustraliaA
EP0912575A1European Patent Office (EPO)A1
CA2313150A1CanadaA1
WO9929694A1World Intellectual Property Organization (WIPO)A1
CA2313004A1CanadaA1
CA2314335A1CanadaA1
WO9931102A1World Intellectual Property Organization (WIPO)A1
WO9931103A1World Intellectual Property Organization (WIPO)A1
WO9931104A1World Intellectual Property Organization (WIPO)A1
WO9931105A1World Intellectual Property Organization (WIPO)A1
AU1820899AAustraliaA
AU1722899AAustraliaA
AU1722999AAustraliaA
AU1723099AAustraliaA
AU1815999AAustraliaA
US5922751AUnited States of AmericaA
US5977119AUnited States of AmericaA
KR100237962B1Republic of KoreaB1
US6025361AUnited States of AmericaA
US6037470AUnited States of AmericaA
JP2000080087AJapanA
US6040447AUnited States of AmericaA
US6057445AUnited States of AmericaA
US6066641AUnited States of AmericaA
NO20002998D0NorwayD0
US6075016AUnited States of AmericaA
JP2000507599AJapanA
JP3056788B2JapanB2
US6090816AUnited States of AmericaA
NO20002998LNorwayL
GB0013780D0United KingdomD0
GB0013781D0United KingdomD0
IL115563AIsraelA
US6103749AUnited States of AmericaA
GB2346878AUnited KingdomA
GB2346879AUnited KingdomA
BR9815169ABrazilA
BR9815170ABrazilA
BR9815171ABrazilA
CA2362116A1CanadaA1
CA2367143A1CanadaA1
WO0059449A2World Intellectual Property Organization (WIPO)A2
WO0059499A1World Intellectual Property Organization (WIPO)A1
Showing 100 of 209